trans-Fatty acids, insulin resistance/diabetes, and cardiovascular disease risk: Should policy decisions be based on observational cohort studies, or should we be waiting for results from randomized placebo-controlled trials?

Metabolism: Clinical and Experimental

Volumn 60, Issue 7, 2011, Pages 901-905

  Aronis, Konstantinos N ^a   Joseph, Richard J ^a   Blackburn, George L ^a   Mantzoros, Christos ^a,b,c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; LINOLENIC ACID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOUNSATURATED FATTY ACID; PALMITIC ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; TRANS FATTY ACID; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR RECEPTOR 1; VASCULAR CELL ADHESION MOLECULE 1;

CALORIC INTAKE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; COMMERCIAL PHENOMENA; COST EFFECTIVENESS ANALYSIS; DAIRY PRODUCT; DIABETES MELLITUS; EDITORIAL; ENDOTHELIAL DYSFUNCTION; ENERGY TRANSFER; ERYTHROCYTE; FAT INTAKE; FIBRINOGEN BLOOD LEVEL; FRUIT; GOVERNMENT; HEALTH CARE POLICY; HEART ARREST; HEART DEATH; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTRAABDOMINAL FAT; ISCHEMIC HEART DISEASE; LIPID DIET; LIPOPROTEIN BLOOD LEVEL; MEAT; MEDITERRANEAN DIET; METABOLIC SYNDROME X; OBESITY; OBSERVATIONAL STUDY; ORAL GLUCOSE TOLERANCE TEST; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUERTO RICO; RANDOMIZED CONTROLLED TRIAL (TOPIC); TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES; VEGETABLE;

CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIETARY FATS, UNSATURATED; FEMALE; HEALTH POLICY; HUMANS; INSULIN RESISTANCE; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRANS FATTY ACIDS;

EID: 79959356776     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2011.04.003     Document Type: Editorial

References (49)

1. Kung HC, Hoyert DL, Xu J, et al. Deaths: final data for 2005. Natl Vital Stat Rep 2008;56:1-120.
2. American Heart Association. Cardiovascular disease death rates decline, but risk factors still exact heavy toll. Accessed at http://www.sciencedaily. com/releases/2007/12/071220152553.htm on March 25, 2011.
3. Freedman DS. Obesity - United States, 1988-2008. MMWR Surveill Summ 2011;60:73-7.
4. Center of Disease Control and Prevention. Number (in millions) of civilian, non-institutionalized persons with diagnosed diabetes, United States, 1980-2008. Accessed at http://www.cdc.gov/diabetes/statistics/prev/national/ figpersons.htm on February 23, 2011.
5. Micha R, Mozaffarian D. Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes. Nat Rev Endocrinol 2009;5:335-44.
6. Remig V, Franklin B, Margolis S, et al. Trans fats in America: a review of their use, consumption, health implications, and regulation. J Am Diet Assoc 2010;110:585-92.
7. Harnack L, Lee S, Schakel SF, et al. Trends in the trans-fatty acid composition of the diet in a metropolitan area: the Minnesota Heart Survey. J Am Diet Assoc 2003;103:1160-6. (Pubitemid 39348740)
8. Stender S, Astrup A, Dyerberg J. Ruminant and industrially produced trans fatty acids: health aspects. Food Nutr Res 2008;52 doi:10.3402/fnr.v52i0.1651.
9. Eckel RH, Borra S, Lichtenstein AH, et al. Understanding the complexity of trans fatty acid reduction in the American diet: American Heart Association Trans Fat Conference 2006: report of the Trans Fat Conference Planning Group. Circulation 2007;115:2231-46.
10. Lichtenstein AH, Appel LJ, Brands M, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006;114:82-96.
11. Center for Science in the Public Interest. Trans fat bans in restaurants and schools. Accessed at http://www.cspinet. org/transfat/2008 on February 23, 2011.
12. National Conference of State Legislatures. (Updated January 2011) Trans fat and menu labeling legislation. Accessed at http://www.ncsl.org/default.aspx? tabid=14362 on February 23, 2011.
13. Harnack LJ, Rydell SA, Stang J. Prevalence of use of herbal products by adults in the Minneapolis/St Paul, Minn, metropolitan area. Mayo Clin Proc 2001;76:688-94. (Pubitemid 32595420)
14. Bassett CM, McCullough RS, Edel AL, et al. Trans-fatty acids in the diet stimulate atherosclerosis. Metabolism 2009;58: 1802-8.
15. Mensink RP, Katan MB. Effect of dietary trans fatty acids on high-density and low-density lipoprotein cholesterol levels in healthy subjects. N Engl J Med 1990;323:439-45. (Pubitemid 20231555)
16. Zock PL, Katan MB. Hydrogenation alternatives: effects of trans fatty acids and stearic acid versus linoleic acid on serum lipids and lipoproteins in humans. J Lipid Res 1992;33:399-410.
17. Wood R, Kubena K, O'Brien B, et al. Effect of butter, mono- and polyunsaturated fatty acid-enriched butter, trans fatty acid margarine, and zero trans fatty acid margarine on serum lipids and lipoproteins in healthy men. J Lipid Res 1993;34: 1-11. (Pubitemid 23016616)
18. Mauger JF, Lichtenstein AH, Ausman LM, et al. Effect of different forms of dietary hydrogenated fats on LDL particle size. Am J Clin Nutr 2003;78:370-5. (Pubitemid 39663501)
19. Mensink RP, Zock PL, Kester AD, et al. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003;77: 1146-55. (Pubitemid 44858429)
20. Mozaffarian D, Clarke R. Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur J Clin Nutr 2009;63(Suppl 2):S22-S33.
21. Chardigny JM, Destaillats F, Malpuech-Brugere C, et al. Do trans fatty acids from industrially produced sources and from natural sources have the same effect on cardiovascular disease risk factors in healthy subjects? Results of the trans Fatty Acids Collaboration (TRANSFACT) study. Am J Clin Nutr 2008;87:558-66. (Pubitemid 351364535)
22. Motard-Belanger A, Charest A, Grenier G, et al. Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am J Clin Nutr 2008;87:593-9. (Pubitemid 351364539)
23. Willett W, Mozaffarian D. Ruminant or industrial sources of trans fatty acids: public health issue or food label skirmish? Am J Clin Nutr 2008;87:515-6.
24. Mozaffarian D, Pischon T, Hankinson SE, et al. Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr 2004;79:606-12. (Pubitemid 41103904)
25. Lopez-Garcia E, Schulze MB, Meigs JB, et al. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr 2005;135: 562-6. (Pubitemid 40365218)
26. Baer DJ, Judd JT, Clevidence BA, et al. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr 2004;79:969-73. (Pubitemid 41095947)
27. Kavanagh K, Jones KL, Sawyer J, et al. Trans fat diet induces abdominal obesity and changes in insulin sensitivity in monkeys. Obesity (Silver Spring) 2007;15:1675-84. (Pubitemid 47264946)
28. Koh-Banerjee P, Chu NF, Spiegelman D, et al. Prospective study of the association of changes in dietary intake, physical activity, alcohol consumption, and smoking with 9-y gain in waist circumference among 16,587 US men. Am J Clin Nutr 2003;78:719-27. (Pubitemid 39663489)
29. Field AE, Willett WC, Lissner L, et al. Dietary fat and weight gain among women in the Nurses' Health Study. Obesity (Silver Spring) 2007;15:967-76. (Pubitemid 46740972)
30. Christiansen E, Schnider S, Palmvig B, et al. Intake of a diet high in trans monounsaturated fatty acids or saturated fatty acids. Effects on postprandial insulinemia and glycemia in obese patients with NIDDM. Diabetes Care 1997;20:881-7.
31. Vega-Lopez S, Ausman LM, Jalbert SM, et al. Palm and partially hydrogenated soybean oils adversely alter lipoprotein profiles compared with soybean and canola oils in moderately hyperlipidemic subjects. Am J Clin Nutr 2006;84:54-62. (Pubitemid 44699171)
32. Lovejoy JC, Smith SR, Champagne CM, et al. Effects of diets enriched in saturated (palmitic), monounsaturated (oleic), or trans (elaidic) fatty acids on insulin sensitivity and substrate oxidation in healthy adults. Diabetes Care 2002;25:1283-8. (Pubitemid 41071133)
33. Louheranta AM, Turpeinen AK, Vidgren HM, et al. A high-trans fatty acid diet and insulin sensitivity in young healthy women. Metabolism 1999;48:870-5. (Pubitemid 29310042)
34. Hu FB, Manson JE, Stampfer MJ, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001;345:790-7.
35. Meyer KA, Kushi LH, Jacobs Jr DR, et al. Dietary fat and incidence of type 2 diabetes in older Iowa women. Diabetes Care 2001;24:1528-35. (Pubitemid 33716444)
36. van Dam RM, Willett WC, Rimm EB, et al. Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care 2002;25:417-24. (Pubitemid 41103330)
37. Willett WC, Stampfer MJ, Manson JE, et al. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 1993;341:581-5. (Pubitemid 23066144)
38. Lemaitre RN, King IB, Sotoodehnia N, et al. Endogenous red blood cell membrane fatty acids and sudden cardiac arrest. Metabolism 2010;59:1029-34.
39. Lemaitre RN, King IB, Sotoodehnia N, et al. Red blood cell membrane alpha-linolenic acid and the risk of sudden cardiac arrest. Metabolism 2009;58:534-40.
40. Bendsen NT, Larsen TM, Chabanova E, et al. Effect of trans fatty acid intake on insulin sensitivity and intramuscular lipids - a randomized trial in overweight postmenopausal women. Metabolism 2011 (in press).
41. Tardy AL, Lambert-Porcheron S, Malpuech-Brugere C, et al. Dairy and industrial sources of trans fat do not impair peripheral insulin sensitivity in overweight women. AmJ Clin Nutr 2009;90:88-94.
42. Scarborough P, Nnoaham KE, Clarke D, et al. Modelling the impact of a healthy diet on cardiovascular disease and cancer mortality. J Epidemiol Community Health 2010 doi:10.1136/jech.2010.114520.
43. Fung TT, Rexrode KM, Mantzoros CS, et al. Mediterranean diet and incidence of and mortality from coronary heart disease and stroke in women. Circulation 2009;119:1093-100.
44. Yannakoulia M, Yiannakouris N, Melistas L, et al. A dietary pattern characterized by high consumption of whole-grain cereals and low-fat dairy products and low consumption of refined cereals is positively associated with plasma adiponectin levels in healthy women. Metabolism 2008;57: 824-30. (Pubitemid 351711655)
45. Mantzoros CS, Williams CJ, Manson JE, et al. Adherence to the Mediterranean dietary pattern is positively associated with plasma adiponectin concentrations in diabetic women. Am J Clin Nutr 2006;84:328-35. (Pubitemid 44699141)
46. Magkos F, Yannakoulia M, Chan JL, et al. Management of the metabolic syndrome and type 2 diabetes through lifestyle modification. Annu Rev Nutr 2009;29:223-56.
47. Look AHEAD Research GroupWing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med 2010;170: 1566-75.
48. Oh EG, Bang SY, Hyun SS, et al. Effects of a 6-month lifestyle modification intervention on the cardiometabolic risk factors and health-related qualities of life in women with metabolic syndrome. Metabolism 2010;59:1035-43.
49. Suzuki A, Binks M, Sha R, et al. Serum aminotransferase changes with significant weight loss: sex and age effects. Metabolism 2010;59:177-85.